DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

5.83 0.12 (2.10%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARIA $5.83 2.10%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.74
Previous Close $5.71
Daily Range $5.54 - $5.86
52-Week Range $2.15 - $9.83
Market Cap $1.1B
P/E Ratio -4.33
Dividend (Yield) $0.00 (0.0%)
Volume 5,515,667
Average Daily Volume 7,354,423
Current FY EPS -$1.18

Sector

Healthcare

Industry

Drugs

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/

News & Commentary Rss Feed

Why Ariad Pharmaceuticals, Inc. Stock Catapulted Higher

Ariad Pharmaceuticals stock is among today's top gainers after the Food and Drug Administration divvies a prized designation one of Ariad's pipeline products.

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today

ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog

Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog

ARIAD Announces Recommendation For Iclusig By The Pharmacovigilance Risk Assessment Committee Of The

ARIAD Announces Recommendation For Iclusig By The Pharmacovigilance Risk Assessment Committee Of The European Medicines Agency

ARIAD Gets Breakthrough Therapy Designation for AP26113 - Analyst Blog

ARIAD Pharmaceuticals' All-In Bet On Europe

5 Stocks Under $10 Making Big Moves Higher

See More ARIA News...

ARIA's Top Competitors

ARIA $5.83 (2.10%)
Current stock: ARIA
AMGN $147.26 (0.01%)
Current stock: AMGN
GILD $110.71 (3.29%)
Current stock: GILD
BIIB $321.67 (1.77%)
Current stock: BIIB